COVID-19对欧洲核医学的影响
该综述检索PubMed截至2021年1月21日的COVID-19相关文献,总结疫情对欧洲核医学部门的影响。疫情导致人力减少、诊断与治疗操作量显著下降、放射性药物供应或技术支援延迟,各部门采取感染控制措施并开展远程医疗以维持患者医疗。
要点
- 疫情使欧洲几乎所有核医学中心因人员感染COVID-19等原因出现人力减少。
- 核医学部门采取环境与个人卫生、社交距离、非高优先级操作改期、正确使用个人防护装备等措施限制传播。
- 疫情导致诊断与治疗核医学操作量显著下降,并延迟了放射性药物供应或技术支援。
核心结论
- COVID-19疫情重塑了欧洲核医学部门的人力资源、患者诊疗管理、操作模式、放射性药物供应、教学培训与研究。
- 尽管资源可用性受限,仍需在维持感染控制措施的同时为脆弱患者提供连续性医疗。
研究设计与样本
- 综述,在PubMed检索截至2021年1月21日发表的COVID-19相关文献。
- 按核医学部门的一般活动与特定活动归纳研究结果。
主要发现
- 欧洲几乎所有中心因人员确诊COVID-19及冠状病毒相关其他原因出现人力减少。
- 部分部门在疫情期间经历放射性药物供应或技术支援延迟。
- 疫情导致诊断与治疗核医学操作显著减少,非COVID-19疾病(如癌症或急性心血管疾病)患者的照护水平降低。
- 已建立远程医疗服务以维持对患者的医疗协助。
临床怎么用
- 核医学部门应实施环境与个人卫生、社交距离、非高优先级操作改期、正确使用个人防护装备及快速识别疑似COVID-19病例等措施。
- 利用远程医疗服务维持患者医疗协助。
- 在维持感染控制措施的同时,优先保障脆弱患者的连续性照护。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The COVID-19 pandemic has profoundly changed hospital activities, including nuclear medicine (NM) practice. This review aimed to determine and describe the impact of COVID-19 on NM in Europe and critically discuss actions and strategies applied to face the pandemic. A literature search for relevant articles was performed on PubMed, covering COVID-19 studies published up until January 21, 2021. The findings were summarized according to general and specific activities within the NM departments. The pandemic strongly challenged NM departments: a reduction in the workforce has been experienced in almost every center in Europe due to personnel diagnosed with COVID-19 and other reasons related to the coronavirus. NM departments introduced procedures to limit COVID-19 transmission, including environmental and personal hygiene, social distancing, rescheduling of non-high-priority procedures, the correct use of personal protective equipment, and prompt identification of suspect COVID-19 cases. A proportion of the departments experienced a delay in radiopharmaceuticals supply or technical assistance during the pandemic. Furthermore, the pandemic resulted in a significant reduction of diagnostic and therapeutic NM procedures, as well as a reduced level of care for patients affected by diseases other than COVID-19, such as cancer or acute cardiovascular disease. Telemedicine services have been set up to maintain medical assistance for patients. COVID-19 pandemic has reshaped human work resources, patient's diagnostic and therapeutic management, operative models, radiopharmaceutical supplies, teaching, training and research of NM departments. Limits of availability of resources emerged. Nonetheless, we have to provide continuity in care, especially for fragile patients, maintaining infection control measures. Challenges that have been faced should reshape our vision and get us prepared for the future.
引用
- Kirienko M, Telo S, Hustinx R, et al. The Impact of COVID-19 on Nuclear Medicine in Europe. Semin Nucl Med. 2021. PMID: 34325819. doi:10.1053/j.semnuclmed.2021.06.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。